NovelStem International Corp. (NSTM)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
At close: Mar 2, 2026
NovelStem International Company Description
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy.
The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018.
NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.
NovelStem International Corp.
| Country | United States |
| Founded | 1993 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 15 |
Contact Details
Address: 2255 Glades Road Boca Raton, Florida 33431 United States | |
| Phone | 410 598 9024 |
| Website | novelstem.com |
Stock Details
| Ticker Symbol | NSTM |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US67001V1098 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jan H. Loeb | Executive Chairman and President |
| Mitchell Rubenstein J.D. | Co-Founder and Independent Director |
| Christine Jenkins | Vice President, Chief Financial Officer and Secretary |
| David Collins | Investor Relations Firm, Catalyst IR |